PLRX
Pliant Therapeutics Inc
1.10$
+1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -55.6% | +10.6% | +21.2% | -14.5% | +113.3% | -60.5% | -0.2% | – | – | -27.7% | – | – | |
| – | – | -111.7% | – | – | – | -139.5% | – | – | – | – | – | – | |
| – | +2.6% | +10.4% | +22.8% | +6.1% | -18.8% | +12.0% | -25.9% | -44.3% | -13.1% | -14.5% | +25.6% | – | |
| – | -9.7% | +10.0% | -1.5% | -5.1% | +1.9% | +6.7% | -13.6% | -22.9% | -25.5% | +6.4% | -12.9% | – | |
| – | -1.4% | +10.3% | +15.7% | +3.3% | -14.0% | +10.5% | -23.4% | -37.4% | -16.6% | -8.8% | +10.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +38.6% | +95.1% | +1.0% | -4.9% | -4.2% | +1.3% | +0.7% | -83.3% | +1,173.5% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -86.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.